LUCI DAVID P has filed 7 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 250000 shares of Acurx Pharmaceuticals, Inc. ($ACXP) on February 05, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2025 | Acurx Pharmaceuticals, Inc. | $ACXP | LUCI DAVID P | President and CEO | A | Stock Option | 250000 | $0.00 | 250,000.0000 | 16,163,366 | 9999.99% | 1.55% |
| Jan. 6, 2025 | Acurx Pharmaceuticals, Inc. | $ACXP | LUCI DAVID P | President and CEO | P | Common Stock | 49261 | $1.02 | 1,147,541.0000 | 16,163,366 | 4.49% | 0.30% |
| Jan. 6, 2025 | Acurx Pharmaceuticals, Inc. | $ACXP | LUCI DAVID P | President and CEO | P | Warrants for Common Stock | 49261 | $0.00 | 49,261.0000 | 16,163,366 | 9999.99% | 0.30% |
| Feb. 23, 2024 | Acurx Pharmaceuticals, Inc. | $ACXP | LUCI DAVID P | President and CEO | A | Stock Option | 250000 | $0.00 | 250,000.0000 | 12,671,572 | 9999.99% | 1.97% |
| Jan. 3, 2024 | Acurx Pharmaceuticals, Inc. | $ACXP | LUCI DAVID P | President and CEO | M | Common Stock | 19737 | $3.55 | 1,098,280.0000 | 12,671,572 | 1.83% | 0.16% |
| Jan. 3, 2024 | Acurx Pharmaceuticals, Inc. | $ACXP | LUCI DAVID P | President and CEO | M | Warrants for Common Stock | 19737 | $0.00 | 0.0000 | 12,671,572 | 100.00% | 0.16% |
| Feb. 13, 2023 | Acurx Pharmaceuticals, Inc. | $ACXP | LUCI DAVID P | President and CEO | A | Stock Option | 130000 | $0.00 | 130,000.0000 | 10,816,412 | 9999.99% | 1.20% |